IDEXX Laboratories Inc. (IDXX) Social Stream



IDEXX Laboratories Inc. (IDXX): $477.67

5.85 (-1.21%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

A

IDEXX LABORATORIES INC (IDXX) Price Targets From Analysts

Use the tables below to see what analysts covering IDEXX LABORATORIES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 7 $750 $700 $718.75 $538.5 33.47%
2021-11-18 8 $750 $700 $721.4 $538.5 33.96%
2022-01-31 7 $750 $600 $701.4 $538.5 30.25%
2022-02-03 7 $750 $605 $702.4 $538.5 30.44%
2022-02-18 9 $750 $605 $693.666 $538.5 28.81%
2022-04-26 8 $750 $605 $693.666 $538.5 28.81%
2022-05-02 8 $750 $550 $684.5 $538.5 27.11%
2022-05-05 8 $750 $470 $633 $538.5 17.55%
2022-08-01 9 $750 $415 $546 $538.5 1.39%
2022-08-02 9 $650 $415 $516.857 $538.5 -4.02%
2022-08-04 10 $573 $415 $470.428 $538.5 -12.64%
2022-08-08 10 $582 $415 $484.375 $538.5 -10.05%
2022-10-10 10 $582 $415 $494.375 $538.5 -8.19%
2022-10-17 10 $582 $415 $485 $538.5 -9.94%
2022-10-26 10 $582 $380 $478.125 $538.5 -11.21%
2022-11-02 10 $582 $380 $475.625 $538.5 -11.68%
2022-11-13 10 $582 $415 $480.625 $538.5 -10.75%
2022-12-15 10 $582 $415 $476.875 $538.5 -11.44%
2023-01-18 10 $582 $415 $486.875 $538.5 -9.59%
2023-01-26 10 $582 $415 $498.75 $538.5 -7.38%
2023-01-30 10 $582 $415 $508.125 $538.5 -5.64%
2023-02-03 10 $582 $470 $518.75 $538.5 -3.67%
2023-02-08 10 $582 $470 $528.125 $538.5 -1.93%
2023-02-15 10 $600 $500 $557.875 $538.5 3.6%
2023-04-24 10 $600 $500 $563.75 $538.5 4.69%
2023-07-21 8 $600 $500 $557.5 $538.5 3.53%
2023-08-01 8 $610 $500 $558.75 $538.5 3.76%
2023-08-27 8 $600 $525 $576.25 $538.5 7.01%
2023-09-15 8 $600 $500 $573.125 $538.5 6.43%
2023-10-12 8 $600 $500 $563.125 $538.5 4.57%
2023-11-01 8 $600 $460 $558.125 $538.5 3.64%
2023-11-02 8 $600 $440 $542.125 $538.5 0.67%
2023-11-06 8 $600 $440 $536.5 $538.5 -0.37%
2023-12-12 10 $600 $440 $553.75 $538.5 2.83%
2023-12-15 11 $602 $440 $559.111 $538.5 3.83%

The Trend in the Analyst Price Target


IDXX's average price target has moved up $40.36 over the prior 45 weeks.

Over the past 47 weeks, IDXX's average upside potential has been 16.24%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 10 582 415 498.750 487.00 2.41%
2023-03-23 10 600 500 563.750 478.74 17.76%
2023-05-03 9 600 500 563.750 478.83 17.73%
2023-11-02 8 600 440 542.125 419.44 29.25%
2023-11-06 10 600 440 536.500 423.02 26.83%

IDXX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.59 7 1 3 0 0 11

The Trend in the Broker Recommendations


IDXX's average broker recommendation rating improved by 0.08 over the prior 17 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, IDEXX LABORATORIES INC's average analyst price target is higher than 4335.59% of them.
  • In the context of Pharmaceutical Products stocks, IDEXX LABORATORIES INC's variance in analysts' estimates is lower than -551.95% of them.
  • In terms of how IDEXX LABORATORIES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 702.54% of that group.
  • In terms of how IDEXX LABORATORIES INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is greater than 902.8% of that group.

In the Pharmaceutical Products industry, QDEL, GMAB, and ELAN are the three stocks most similar to IDEXX LABORATORIES INC regarding the price target and analyst recommendation information presented here.

Is IDXX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!